Humana Reports Third Quarter 2021 Financial Results; Revises Full Year 2021 EPS Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Humana (HUM) PT Lowered to $480 at Cantor Fitzgerald
November 3, 2021 11:11 AM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Humana (NYSE: HUM) to $480.00 (from $508.00) while maintaining an Overweight rating.
The analyst commented, ". We reiterate our Overweight rating on HUM shares but reduce our price target to $480 from $508. This morning, November 3, the company reported 3Q21 results which on... More
Humana (HUM) Tops Q3 EPS by 17c, Updates FY Guidance
November 3, 2021 6:35 AM EDTHumana (NYSE: HUM) reported Q3 EPS of $4.83, $0.17 better than the analyst estimate of $4.66. Revenue for the quarter came in at $20.7 billion versus the consensus estimate of $20.91 billion.
GUIDANCE:
Humana sees Q4 2021 EPS of $20.50, versus the consensus of... More
